Clinical Trial Update: Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis [EARLY_Phase 1]

View source ↗

Summary

An early-phase Phase 1 study evaluated the prevalence of transthyretin cardiac amyloidosis among patients with clinically significant aortic stenosis; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis
• Transthyretin Cardiac Amyloidosis

Snippet

Sponsor: Mayo Clinic | Conditions: Aortic Stenosis, Transthyretin Amyloidosis | EARLY_Phase 1 | Status: COMPLETED